These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9840353)

  • 1. The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndrome.
    Patzold T; Sindern E; Ossege-Pohle L; Malin JP
    J Neurol; 1998 Dec; 245(12):803-8. PubMed ID: 9840353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barré syndrome and multiple sclerosis.
    Vedeler CA; Matre R; Sadallah S; Schifferli J
    J Neuroimmunol; 1996 Jun; 67(1):17-20. PubMed ID: 8707926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of soluble tumor necrosis factor receptor in patients with multiple sclerosis and HTLV-1-associated myelopathy.
    Matsuda M; Tsukada N; Miyagi K; Yanagisawa N
    J Neuroimmunol; 1994 Jun; 52(1):33-40. PubMed ID: 8207119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble intercellular adhesion molecule-I (sICAM-I) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system.
    Trojano M; Avolio C; Ruggieri M; De Robertis F; Giuliani F; Paolicelli D; Livrea P
    Mult Scler; 1998 Feb; 4(1):39-44. PubMed ID: 9532592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid levels of soluble tumour necrosis factor receptor in acute encephalitis.
    Ichiyama T; Hayashi T; Nishikawa M; Furukawa S
    J Neurol; 1996 Jun; 243(6):457-60. PubMed ID: 8803818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum tumour necrosis factor-alpha and soluble tumour necrosis factor receptors levels in patients with Guillain-Barre syndrome.
    Radhakrishnan VV; Sumi MG; Reuben S; Mathai A; Nair MD
    Acta Neurol Scand; 2004 Jan; 109(1):71-4. PubMed ID: 14653854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Cerebrospinal Fluid Balance of TNF and TNF Receptors in Naïve Multiple Sclerosis Patients: Early Involvement in Compartmentalised Intrathecal Inflammation.
    Magliozzi R; Pezzini F; Pucci M; Rossi S; Facchiano F; Marastoni D; Montagnana M; Lippi G; Reynolds R; Calabrese M
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum levels of soluble tumor necrosis factor receptors (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection.
    Weiss M; Martignoni M; Petropoulou T; Sölder B; Belohradsky BH
    Infection; 1996; 24(4):301-8. PubMed ID: 8875282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor necrosis factor (TNF)-alpha and soluble TNF-alpha receptors in patients with Guillain-Barré syndrome.
    Créange A; Bélec L; Clair B; Raphaël JC; Gherardi RK
    J Neuroimmunol; 1996 Aug; 68(1-2):95-9. PubMed ID: 8784265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of soluble tumor necrosis factor receptors 1 and 2 in multiple sclerosis patients treated with interferon beta-1b.
    Laske C; Oschmann P; Tofighi J; Kühne BS; Diehl H; Bregenzer T; Kraus J; Chatzimanolis N; Bauer R; Traupe H; Kaps M
    Eur Neurol; 2001; 46(4):210-4. PubMed ID: 11721129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A soluble form of tumour necrosis factor receptor in cerebrospinal fluid and serum of HTLV-I-associated myelopathy and other neurological diseases.
    Puccioni-Sohler M; Rieckmann P; Kitze B; Lange P; Albrecht M; Felgenhauer K
    J Neurol; 1995 Mar; 242(4):239-42. PubMed ID: 7798123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
    Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P
    Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system.
    Kastenbauer S; Koedel U; Wick M; Kieseier BC; Hartung HP; Pfister HW
    J Neuroimmunol; 2003 Apr; 137(1-2):210-7. PubMed ID: 12667665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.
    Trojano M; Avolio C; Simone IL; Defazio G; Manzari C; De Robertis F; Calò A; Livrea P
    Neurology; 1996 Dec; 47(6):1535-41. PubMed ID: 8960741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum levels of tumor necrosis factor alpha and soluble tumor necrosis factor-receptor I in asthmatic patients and patients with chronic respiratory tract infection].
    Sumitomo M; Suda S; Shindo K; Fukumura M; Fukushima J; Okuda K; Ito A
    Arerugi; 1997 Nov; 46(11):1136-47. PubMed ID: 9436331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H
    Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [TNF-alpha and soluble TNF receptor p55 in patients wtih multiple sclerosis].
    Geppert A; Losy J
    Neurol Neurochir Pol; 1999; 33(4):807-14. PubMed ID: 10612095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
    Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor alpha and its receptors in relapsing-remitting multiple sclerosis.
    Martino G; Consiglio A; Franciotta DM; Corti A; Filippi M; Vandenbroeck K; Sciacca FL; Comi G; Grimaldi LM
    J Neurol Sci; 1997 Nov; 152(1):51-61. PubMed ID: 9395126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis: prospective analysis of TNF-alpha and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity.
    Spuler S; Yousry T; Scheller A; Voltz R; Holler E; Hartmann M; Wick M; Hohlfeld R
    J Neuroimmunol; 1996 May; 66(1-2):57-64. PubMed ID: 8964914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.